Partner Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-55,719
Closed -$3.52M 113
2018
Q1
$3.52M Buy
+55,719
New +$3.58M 3.81% 2
2016
Q3
Sell
-9,099
Closed -$584K 89
2016
Q2
$669K Sell
9,099
-25,588
-74% -$1.81M 1.09% 41
2016
Q1
$2.22M Sell
34,687
-14,235
-29% -$898K 3.61% 3
2015
Q4
$3.37M Buy
48,922
+14,279
+41% +$944K 5.52% 2
2015
Q3
$2.05M Sell
34,643
-1,499
-4% -$95.1K 3.1% 9
2015
Q2
$2.4M Buy
36,142
+21,973
+155% +$1.45M 3.38% 4
2015
Q1
$914K Buy
+14,169
New +$887K 1.38% 31
2014
Q2
Sell
-754,383
Closed -$39.2M 65
2014
Q1
$39.2M Buy
754,383
+91,585
+14% +$4.87M 7.23% 2
2013
Q4
$35.2M Buy
+662,798
New +$33.8M 7.99% 1

Other funds holding BMY

Partner Investment Management's BMY Position: Q2 2018 in Review

Partner Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 55,719 shares — an estimated $3.52M sold.

Partner Investment Management first reported a position in BMY in Q4 2013 and held it in 9 quarters. The position peaked at $39.2M in Q1 2014. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Partner Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Partner Investment Management sold 55,719 Bristol-Myers Squibb shares in Q2 2018, an estimated $3.52M.
  • Partner Investment Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 9 quarters.
  • Partner Investment Management's Bristol-Myers Squibb position peaked at $39.2M in Q1 2014.
  • 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.